Lipitor's $131B lifetime sales dwarf other megablockbusters

The names of the five best-selling drugs of all time aren't much of a surprise: Lipitor, Plavix, Zocor, Seretide/Advair, and Nexium. But what might be surprising are the figures attached. Pfizer's cholesterol drug Lipitor has brought in $131 billion over its lifetime, with the Sanofi/Bristol-Myers Squibb blood thinner Plavix lagging far behind in second place with $60 billion. Report

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.